Popular Articles

Pfizer's Sutent Is Recommended For Reimbursement For Gastrointestinal Stromal Tumor Patients By British Health Agency
Pfizer Inc said that the United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal document (FAD) recommending reimbursement for Sutent (sunitinib malate) as a second-line treatment for patients with advanced gastrointestinal stromal tumor (GIST). This recommendation follows NICE"s recently published guidance recommending reimbursement for Sutent for the first-line treatment of advanced kidney cancer.
drugs without prescription
Medigap Plans In Illinois To Benefit From Medicare Advantage Reimbursement Cuts
HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that planned cuts to Medicare Advantage reimbursement will benefit organizations offering Medicare supplement plans in Illinois. According to the recent Illinois Health Plan Analysis, the shift from Medicare Advantage to Medicare supplement plans, also known as Medigap plans, will likely benefit Blue Cross Blue Shield of Illinois, the state"s top Medigap insurer.
News of the day
Teens' Risk Factors For Heart Disease, Diabetes Reduced By Lap Band Weight Loss Surgery
In teenagers, laparoscopic gastric banding surgery for treatment of extreme obesity can significantly improve and even reverse the metabolic syndrome, a new study found. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
Mental Health

New Homeopathic Spray Offers Fast, Short-Term Relief From Nicotine Cravings

With rising taxes and increasing restrictions on smoking and tobacco, smokers looking for temporary relief from cravings and withdrawal symptoms during periods when they couldn"t smoke, or chose not to, were out of luck. But a new breed of short-term cessation treatment -- based on age-old homeopathic practices -- promises to help smokers manage cravings on-the-spot, when lighting up isn"t an option. NIX-IT is an oral spray that temporarily relieves nicotine cravings and the uncomfortable symptoms associated with nicotine withdrawal, including anxiety, irritability and dry mouth. Unlike long-term cessation products, NIX-IT acts fast and can be used as-needed, anytime, anywhere. "While NIX-IT can assist adults in quitting tobacco, it isn"t a hardcore stop-smoking product," says Dave Savoca, president of Smokey Mountain Chew, marketing company for NIX-IT. "It"s really targeted to adult tobacco consumers who need to manage tobacco cravings in specific situations. Because it"s easy to carry just about anywhere, NIX-IT is perfect for curbing cravings on long flights, at indoor events, during movies, at restaurants or anywhere else consumers can"t or choose not to smoke." Savoca says NIX-IT, manufactured in the USA at an FDA-regulated facility, falls under the newly-designated category of personal tobacco management, and will be available in retail stores nationwide. NIX-IT


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):